NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 262 filers reported holding NOVOCURE LTD in Q4 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $53,754,000 | +520.0% | 310,642 | +298.8% | 0.33% | +181.9% |
Q3 2020 | $8,670,000 | -100.0% | 77,894 | -86.4% | 0.12% | -68.0% |
Q1 2020 | $36,949,314,000 | -23.4% | 572,680 | 0.0% | 0.36% | +12.4% |
Q4 2019 | $48,259,744,000 | +112590.6% | 572,680 | 0.0% | 0.32% | +8.1% |
Q3 2019 | $42,825,000 | – | 572,680 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |